MetaCap

Xencor Statistics

NASDAQ: XNCRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

33.26-0.75 (-2.21%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Xencor by the numbers

Xencor has a market capitalization of $2.50 billion based on 75.04M shares outstanding. With trailing EPS of $-1.56, Xencor is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.7% above its 50-day average and 78.1% above its 200-day average.

Average daily trading volume is 1.54M shares, or about $51.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

XNCR valuation vs. peer median

XNCR compared with the median of 8 peer companies
MetricXNCRPeer medianDifference
Market cap$2.50B$2.33B+7%
Avg. volume1.54M844.89K+82%

Peer median across 8 companies: IDYA, MBX, ZLAB, PBH, HCM, RCUS, PHVS, PRGO.

Valuation

Price / sales (latest FY)
19.87
EPS (TTM)
$-1.56

Price and trading

Previous close
34.01
Open
33.41
Day range
33.12 – 34.27
52-week range
10.38 – 40.60
52-week change
+109.58%
Beta
—
Volume
1.22M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.50B
Forward Pe
-8.81
Eps
-1.56
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
40.60
Week52 Low
10.38
Avg Volume
1.54M
Shares Outstanding
75.04M
Ma50
28.26
Ma200
18.67
Earnings Date
Nov 4, 2026
Pct From52w High
-18.08%
Pct From52w Low
220.58%

Related